- Issuer ticker
-
ELAN
- Reported as of
-
30 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
03 Nov 2026, 16:51:56 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
Filing notes and source
Key filing fact
Robert M. VanHimbergen filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Nov 2026.
Key facts
- This page summarizes Robert M. VanHimbergen's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Nov 2026, 16:51.
Change
- Previous filing in this sequence was filed on 20 Oct 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001724169
Primary reporting owner
VanHimbergen Robert M
- Relationship
-
EVP and CFO
- Address
- C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
- Signature
- /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
- Signature date
- 03 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELAN
transaction
Derivative
Deferred Stock Units
Award
- Transaction value
- Shares
- +9
- Change %
- +4.9%
- Price
-
$23.06*
- Shares after
- 184
- Date
- 30 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes